• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding

    The Baseline

    12
    Following
    368
    Stocks Tracked
    49
    Sectors & Interests
    Follow
    Load latest
    logo
    The Baseline
    14 Apr 2023

    Chart of the Week: The best performing direct growth funds

    By Abdullah Shah

    Mutual funds have become an increasingly popular investment option in India, particularly direct growth mutual funds (which have lower expense ratios than regular mutual funds as no intermediary/manager is involved). 

    In this edition of chart of the week, we examine the performance of equity mutual funds from three different angles. The first representation, a heatmap, shows yearly returns of the major mutual fund categories over the past six years. It indicates that equity mutual funds have been under pressure over the past two years due to rising inflation, repo rate hikes, and global conflicts resulting in muted returns.

    Back in 2017, mutual funds posted strong returns, with all categories witnessing double-digit growth and small cap funds recording the highest return of 56.6%. However, in 2018, the performance of mutual funds largely declined – small cap funds fell the most by 16.9%, while multi & flexi cap funds had the highest returns of 5.4%. The Securities and Exchange Board of India (SEBI) changing its regulations regarding asset allocation for mutual fund houses in October 2017 also impacted returns in 2018. In 2021, the lifting Covid-19 lockdowns helped mutual funds post stellar returns, with small cap funds leading the way with 63.3% returns. 

    2022 is a different story. As we can see in the second chart, sectoral/thematic funds dominate the top-performing mutual funds over the past year. Kotak Infra & Econ Reform Dir Gr had the highest returns of 18.9% over the past year, while it rose 13.5% over the past five years. Also, the safe-haven asset, gold hitting all-time highs in India amid recession fears, helped mutual funds investing in gold post strong returns in the past year.

    How has performance been over the long term? The third chart shows that Quant Small Cap Dir Gr has the highest five-year annualized returns of 23.9%, outperforming the small-cap funds category by 8.5 percentage points. Quant Tax Plan Dir Gr returned 22.2% over the past five years, enabling the fund to outperform its ELSS category by 12.1 percentage points over the same period

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    13 Apr 2023
    Screener of the week:  Nifty 500 companies that will gain from shifting global supply chains

    Screener of the week: Nifty 500 companies that will gain from shifting global supply chains

    By Abdullah Shah

    This week, we take a look at stocks that stand to gain from the China+1 strategy. This screener reflects companies that have a global presence and are likely to see QoQ revenue growth of over 5% in Q4FY23 and revenue growth of over 10% YoY in FY23.

    Industries like electrical equipment, pharmaceuticals and consumer electronics feature in the screener. Major stocks in the screener are Larsen & Toubro, Varun Beverages, Havells India, Voltas, Natco Pharma and Amber Enterprises.

    Natco Pharma may see the highest revenue growth of 70% QoQ in Q4FY23, according to Trendlyne’s forecaster. ICICI Direct reports that the company plans to expand its presence in other geographies and in the crop protection segment in Brazil, Canada and China. This move is likely to contribute significantly to revenue growth in the medium to long-term.

    Forecaster estimates Varun Beverages’ quarterly revenue to increase by 62.1% QoQ in Q4FY23, with an 18.7% YoY growth in revenue for FY23. The  company is set to increase its capacity by 20%, which will be operational before the summer, according to Motilal Oswal.

    Amber Enterprises may clock an estimated revenue growth of 42% QoQ in Q4FY23 and 43.3% YoY in FY23. ICICI Securities sees strong growth from the refrigeration and air conditioning, and electronic component segments, which are focused on exports. 

    You can find some popular screenershere

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    12 Apr 2023
    Can India come out of China's shadow? | Stocks set to gain from shift in global supply chains

    Can India come out of China's shadow? | Stocks set to gain from shift in global supply chains

    By Deeksha Janiani

    The world is a more stressed-out place today compared to five years ago, and a big reason for that is China.

    China's current leader Xi Jinping has proved to be a thin-skinned and power-hungry man. Under him, China has made aggressive territorial claims in the South China Sea, Taiwan and in the Himalayas, causing its relationships with India, the US and Europe to deteriorate. China is fast becoming the unpopular kid in class, and negative views of the country are near historic highs.

    China however, is a major player in global supply chains. These supply chains are increasingly at risk as tensions rise, particularly in the semiconductor chip industry, which is concentrated in a few countries. Taiwan’s TSMC chips for example, account for one-third of new computing supply. These chips power our smartphones, electronics, AI and advanced missiles.

    Faced with Chinese aggression and American sanctions, multinational companies are belatedly trying to diversify their supply chains across industries. Companies like Apple, Google, Sony, Adidas, Nike and Samsung have already set up shop in other Asian countries as a hedge against supply chain risks. This trend is likely to intensify if the relationship between China and the West continues to deteriorate. 

    The global supply chain rejig gives India a once-in-a-millennium opportunity. India has built-in strengths that would help it to take advantage as the world searches for a China alternative: a young workforce, a large base of entrepreneurs and the Centre’s push towards manufacturing. But is India doing enough? 

    In this week’s Analyticks:

    • Can the tiger beat the dragon?: India has a golden chance to boost manufacturing and exports. But there are obstacles in its way  
    • Screener: Indian companies set to gain from shifting global supply chains

    Let’s get into it.


    India needs to get its act together fast, as global supply chains shift away from China  

    This isn’t the first time that China has presented India with an opportunity in world trade. Since 2008, China has been exiting low-cost and labour-intensive manufacturing as it moved up the value chain. This opened up a $150 billion opportunity for India.

    However, India managed to capture only 10-15% of the market vacated by China. Most of this low-end space was snapped up by other Asian countries like Vietnam and Bangladesh. Despite the Indian government's efforts to boost domestic manufacturing with schemes like ‘Make in India’ and PLI, little changed on the ground.

    The share of manufacturing activity in India’s real GDP has remained flat in the past seven years, indicating weak domestic and export demand. Exports clocked a growth of just 4% CAGR in FY15-FY22. 

    Compare this with Vietnam, which saw a sustained rise in its manufacturing activity and double-digit growth in its exports between 2014-21. This was led by sectors like textiles, footwear and furniture. 

    India’s services exports are growing at a much faster clip than goods exports, thanks to business services like accounting, audit and R&D. 

    An unequal relationship: India exports raw materials to China, imports components, finished goods

    India has barely moved up the value chain when it comes to merchandise exports. It was mainly exporting raw materials and intermediate goods to China in 2021. India's mix is comparatively more diverse for the US, as textiles and pharma exports come into play. 

    Over 50% of India’s imports from China consist of capital goods and consumer durables. This reveals a key weakness for India: the lack of a component manufacturing ecosystem.

    It is often cheaper for India Inc to import finished goods and key inputs from China. An IIFT study showed that Indian companies preferred Chinese suppliers across industries like pharma, telecom and textiles, both due to price and better quality. "Without Chinese imports, pharma manufacturing in India would come to a halt," one observer noted.

    However, there are advantages that India can leverage as countries increasingly opt to trade with trusted allies, popularly known as ‘friendshoring’. 

    Where does India hold an edge over China?

    One long-standing factor playing out in China is rising labour wages.This has prompted China to shift away from labour-intensive manufacturing in the past decade.Between 2013 and 2022, hourly wages in China doubled to an average of $8.27, while they remain below $3 in India, Vietnam and Thailand. 

    Business disruptions during China's ‘zero-covid’ days, and the whimsical decisions of a single leader have also sped up the supply-chain ‘de-risking’ drive. In contrast, India offers a stable and democratic government committed to pro-reform policies. 

    India’s younger demographic is also a natural advantage. The median age in India is only 28, while it is 39 in China. Effectively, India has a higher number of young, energetic people available for work in factories. 

    India however, is still struggling with structural problems, many of which came to the forefront during Apple’s recent entry into the country.  

    India has a long way to go before it can emerge as a global manufacturing hub

    Apple faced many teething issues while setting up operations in India, including the inability to find local partners similar to its 150 component suppliers based in China. To manage this, India is giving out faster clearances to Apple’s Taiwanese and Chinese suppliers to set up their presence in India.

    Poor production yields, lack of product designers, and lower flexibility among Indian manufacturers are other gaps Apple is working to resolve. In addition, there is the attitude issue. A former Apple employee interviewed by the Financial Times said that “there just isn’t a sense of urgency” in India. 

    Jamshyd Godrej, Chairman of Godrej & Boyce, highlighted that it’s the ease of doing business which caused Vietnam to jump to the front, ahead of India. He said, “In Vietnam, when you have an industrial park, the park authorities take care of every type of clearance. It is literally a one-stop shop.” 

    India also faces issues such as poor port infrastructure, policy inconsistency, socialist-era labour regulations, and poor learning levels among its students, which must be addressed in order to improve the country's competitiveness in the global manufacturing landscape.

    What can be done to ensure that India doesn’t miss the bus again? Sunil Vachani, chairman at Dixon Technologies, lists three key things that should be prioritized – “We need to achieve large scale in manufacturing to be globally competitive. The time has come for mega factories. We also need a vibrant component ecosystem. And we need to design in India”.

    Fate has smiled upon India owing to China’s missteps. But this time, it is competing with other Asian nations for a larger share in the global manufacturing pie. India will need to think big and act fast to win this race.


    Screener: Nifty 500 companies that will gain from shifting global supply chains

    This week, we take a look at stocks that stand to gain from the China+1 strategy. This screener reflects companies that have a global presence and are likely to see QoQ revenue growth of over 5% in Q4FY23 and revenue growth of over 10% YoY in FY23.

    Industries like electrical equipment, pharmaceuticals and consumer electronics feature in the screener. Major stocks in the screener are Larsen & Toubro, Varun Beverages, Havells India, Voltas, Natco Pharma and Amber Enterprises.

    Natco Pharma may see the highest revenue growth of 70% QoQ in Q4FY23, according to Trendlyne’s forecaster. ICICI Direct reports that the company plans to expand its presence in other geographies and in the crop protection segment in Brazil, Canada and China. This move is likely to contribute significantly to revenue growth in the medium to long-term.

    Forecaster estimates Varun Beverages’ quarterly revenue to increase by 62.1% QoQ in Q4FY23, with an 18.7% YoY growth in revenue for FY23. The  company is set to increase its capacity by 20%, which will be operational before the summer, according to Motilal Oswal.

    Amber Enterprises may clock an estimated revenue growth of 42% QoQ in Q4FY23 and 43.3% YoY in FY23. ICICI Securities sees strong growth from the refrigeration and air conditioning, and electronic component segments, which are focused on exports. 

    You can find some popular screenershere.

    2
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    11 Apr 2023
    Five analyst picks this week

    Five analyst picks this week

    By Suhas Reddy
    1. Motilal Oswal Financial Services: ICICI Securities reiterates its ‘Buy’ call on this financial services company with a target price of Rs 620. This indicates an upside of 39%. Analysts Ansuman Deb, Ravin Kurwa and Vishal Singh say, “Motilal Oswal’s valuations have become attractive considering it is trading at five times FY24 core P/E multiple, which excludes investment income and the investment book.” 

    According to the analysts, Motilal Oswal has seen consistent growth and market share gain in futures and options volumes, and active clients during the past three quarters. The company is also expanding its sales team to drive growth in the housing finance segment, which the analysts believe would yield results in FY24/FY25.

    The analysts add that the company’s efforts to improve its broking volume share and AMC performance, increase wealth management AUM, and grow the housing finance portfolio could benefit earnings. 

    1. Star Health and Allied Insurance: HDFC Securities maintains its ‘Buy’ rating on this insurance company with a target price of Rs 795, indicating an upside of 34.8%. Analysts Sahej Mittal and Krishnan ASV see the recent price hike in the company’s flagship product (STARHEAL) as a key positive, believing it will increase profitability in the coming quarters. They add, “We like STARHEAL for its strong moats, including a dominant agency-led distribution network, retail business mix, and best-in-class operating expense ratios.”

    Despite their optimism about the price hike, the analysts expect it to hit sales in the short term. However, given a favourable base, along with the price hike in the flagship product, they expect the company’s net premium to grow over FY24 by more than 20% YoY. Mittal and Krishnan estimate the firm’s net profit to grow at a CAGR of 26.1% over FY23-25.  

    1. Tata Motors: Motilal Oswal maintains its ‘Buy’ rating on this automobile maker with a target price of Rs 525, implying an upside of 14.6%. Analysts Jinesh Gandhi, Amber Shukla and Aniket Desai are upbeat about the company’s prospects due to JLR’s (Jaguar-Land Rover) wholesales exceeding estimates in Q4FY23. Wholesale volumes have risen 24% YoY to 94,600 units (the brokerage estimate was 84,500 units), driven by a 34% YoY increase in Land Rover’s wholesales. Meanwhile, Jaguar’s wholesales fell 27% YoY. 

    They also find the 30% YoY growth in JLR’s retail sales in Q4 to be encouraging. They add,” Retails were higher in all the markets, with strong growth in EU (+46% YoY), UK (+42% YoY), rest of the world (+30% YoY), China (+29% YoY) and the US (+12% YoY).” 

    Overall, the analysts believe that all of the company’s business segments are in the midst of recovery, but expect supply-side constraints to impact its pace. They see the firm’s domestic, commercial and passenger vehicle businesses driving growth in the medium term. Gandhi, Shukla and Desai expect the company’s revenue to grow at a CAGR of 13.8% over FY23-25. 

    1. Hindalco Industries: ICICI Direct maintains its ‘Buy’ call on this aluminium company but reduces its target price to Rs 465, indicating an upside of 12.3%. According to analyst Dewang Sanghav, who attended Hindalco’s Investor Day events, “Novelis (an arm of Hindalco) aims to achieve long-term sustainable EBITDA/tonne of $525/tonne by Q4FY24.” He also mentions that the company has indicated reduced spending on growth capex for Novelis and Indian operations. Of the $8 billion capex announced a year ago, the company prioritises $4.4 billion capex for projects that are already under construction. The rest of the projects have been deferred but not cancelled.

    Sanghav assumes that Novelis will report an EBITDA of $475/tonne for FY23 and FY24 each. For FY24, he has revised Novelis’s EBITDA/tonne estimate downward to $475/tonne. Going forward, he expects Hindalco to report a consolidated EBITDA margin of 11.3% for FY23 and 11.2% for FY24. 

    1. Godrej Consumer Products: Sharekhan maintains its ‘Buy’ rating on this FMCG company with a target price of Rs 1,100. This implies an upside of 14.8%. Analysts remain optimistic about the company’s growth prospects after reviewing its Q4FY23 pre-quarter update. They are upbeat about the firm’s improved performance and expect its revenue to grow by double digits. They add, “Q4FY23 will be the first quarter of double-digit revenue growth (with volume growth of 4-5%) after six quarters of single-digit growth.” The analysts attribute this growth to healthy domestic business and recovery in its Indonesia business. They expect the firm’s operating and gross margins to improve YoY due to lower input costs.

    The analysts at Sharekhan also note the management’s efforts to improve margins through operational efficiencies and premiumisation. They expect the firm’s revenue to grow at a CAGR of 11.1% over FY22-25. 

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    (You can find all analyst picks here)

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    10 Apr 2023
    Chart of the week: India’s Manufacturing PMI on the rise as other economies slow down

    Chart of the week: India’s Manufacturing PMI on the rise as other economies slow down

    By Abdullah Shah

    The Manufacturing Purchasing Managers' Index (PMI) is a key economic indicator, which measures the health of the country’s manufacturing sector. PMI readings above 50 signal expansion (growth), while those below 50 indicate contraction. In this edition of chart of the week, we will compare the Manufacturing PMI for India to that of  other industrially prominent countries around the world.

    India's manufacturing PMI was strong a year ago in March 2022 with a reading of 54, and remained steady for Q1FY23, clocking in at 53.9 in June 2022. More recently, the PMI has been rising and reached a three-month high of 56.4 in March 2023. The increase was fueled by a capex push from the government in the FY24 budget, as well as the need to achieve the FY23 budget capex goal. 

    In the past two months, China's manufacturing PMI has been around the 50 mark, scoring 51.6 and 50 in February and March 2023, respectively. This indicates a marginal expansion in the sector after the easing of lockdown measures. China’s index had a steep rise at the beginning of FY23 but started a downward slope from July 2022 as lockdown restrictions hit the manufacturing sector. 

    The US PMI was the highest among the five countries a year ago, at 57.1 in March 2022, indicating strong manufacturing activity. However, the index has been on a steady decline since then as the US Fed raised interest rates, and fell below the 50 mark to 46.3 in March 2023. A survey conducted by the Institute for Supply Management (ISM) revealed that all the components of the US PMI were below the 50 mark for the first time since 2008. Analysts suggest that the PMI will continue to fall due to the ever-rising repo rates.

    The United Kingdom's manufacturing PMI was recorded at 55.2 in March 2022 but dropped to 52.8 in June 2022. Although the index rose  for two consecutive months at the beginning of 2023, it declined to 47.9 in March 2023 on the back of reduced demand and manufacturers’ tendency to maintain lower inventory levels.

    Finally, Germany's manufacturing PMI was strong in March 2022 with a reading of 56.9, but it slightly dipped to 54.6 in April. However, the index has continued to fall and hit its lowest level of 44.7 in March 2023.

    The PMI is a crucial instrument to assess the health of the manufacturing sector, and India's manufacturing PMI has been steadily rising in recent months. China's manufacturing PMI also expanded after the lifting of lockdown restrictions, while the US and UK saw declines. Germany's PMI has continued its worrying decline, indicating a sharp slowdown in the country's manufacturing sector. Overall, PMI readings for these countries are a useful recession signal and offer valuable insights into the condition of their economies.

    It remains to be seen how these trends will unfold over the coming months. For now, India is in a relatively strong position.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    06 Apr 2023
    Five Interesting Stocks Today

    Five Interesting Stocks Today

    1. Mahindra & Mahindra Financial Services: This NBFC has risen 5.7% over the past week after posting strong numbers in its business update for Q4FY23 and FY23. This helped the company show up in a screener of stocks with high volume and high gain.

    In Q4FY23, the company’s loan disbursements rose by 50% YoY to Rs 13,750 crore, while FY23 overall saw a jump of 80% YoY Trendlyne’s forecaster estimates the company’s revenue and EPS to grow by 9.6% and 46.5% respectively in FY23.

    The firm’s continued momentum in loan disbursements, improving asset quality and strong collection efficiency are the key drivers for its growth. According to Motilal Oswal, various strategic initiatives like changes in top-level management and improving loan recollection processes have the potential to yield a strong operational performance if executed well. The brokerage maintains its ‘Buy’ rating on the stock, with a target price of Rs 285 per share, indicating a potential upside of 22.8%. It also estimates the lender’s assets under management (AUM) to grow at a CAGR of 18% over FY23-25.

    Recently, the company reached a 52-week high of Rs 272 on February 10, putting it in a screener of stocks with high momentum scores. The stock is currently trading 49.1% higher than its 52-week low of Rs 160.6 per share.

    1. Bajaj Auto: This auto stock's two-wheeler domestic wholesales have risen 42% YoY to 1.5 lakh units in March, while commercial vehicles (CV) saw a surge in domestic wholesales by 74%. However, exports in both segments fell by more than 30%, resulting in a 2% YoY decline in total wholesales (both two-wheeler and CV).
      Recently Bajaj Auto also announced production cuts due to a weak export market, with expectations of a recovery only by Q2FY24. Despite this, the stock has gone up by nearly 12% in the past three months.

    According to ICRA, the commercial vehicles segment is likely to see a growth of 7-10% in FY24. The demand in segments like passenger vehicles, commercial vehicles and tractors will remain healthy and intact, which bodes well for Bajaj Auto, despite a decline in exports.

    On a positive note, Bajaj Auto is set to enter the electric vehicles segment in both the cargo and passenger vehicle markets. In fact, the company is preparing to launch its three-wheeler electric vehicle in April. With a 76% market share in three-wheelers, Bajaj Auto would compete with Mahindra & Mahindra, which currently leads the market in the three-wheeler electric segment.

    In the past week, the stock has risen 5.6% and is currently trading near its 52-week high. It shows up in a screener of stocks with high momentum scores. According to Trendlyne’s Forecaster, the consensus for the stock from 23 analysts is ‘Buy’. The company is set to announce its Q4FY23 results on April 25.

    1. Maruti Suzuki: This automobile manufacturer rose 2.5% on Monday despite reporting a marginal decline of 0.2% YoY in its total domestic sales to 1.7 lakh units in March. The rise in share price is possibly due to the company hiking prices for all its models for a second time in 2023, to partially offset the impact of inflationary pressures and regulatory requirements.

    Although Maruti Suzuki saw a fall in domestic sales, its exports increased 14% YoY in March. The company has shipped over 25 lakh units overseas since it started exports. The automaker exports to nearly 100 countries, including Africa, the Middle East, Latin America and Asia. However, the company’s management has pointed out that a shortage of electronic components affected production volumes in FY23, and expects the problem to persist in FY24. Despite this, the auto giant reported its highest-ever wholesales of 19.7 lakh units, up by 19% YoY, in FY23.

    Analysts have a positive outlook on the company as they believe it is focused on expanding its presence in the SUV segment to drive revenue growth. According to Trendlyne’s Forecaster, the consensus recommendation for the stock from 41 analysts is ‘Buy’. The company features in a screener of stocks where brokers have upgraded their recommendations or target prices in the past three months.

    1. Godrej Consumer Products: This FMCG company released its Q4FY23 business update on Wednesday, forecasting healthy double-digit volume growth in its India business. The firm’s volume growth in Q3 in comparison, was only 3% YoY. Domestic business contributes over 55% of the company’s consolidated revenue. The management expects broad-based growth in Q4, led by the home care and personal care segments.

    The company introduced value products at lower price points across its product portfolios like household insecticides and personal care, amid a sluggish environment in the FMCG sector due to muted rural demand.  This has aided higher market penetration in India, improving the company's volumes. According to reports, the company has gained market share in the hair colour segment after introducing products starting from Rs 15.

    The stock has grown 5.8% over the past 90 days till Wednesday, outperforming the FMCG sector by 8.3 percentage points. The stock shows up in a screener for companies with improving cash flows and high durability scores.

    Motilal Oswal expects the company to benefit significantly from the recent decline in palm oil prices, which could result in improved profitability in the coming quarters. The management also echoes this sentiment, as it believes that the decrease in input costs will allow it to raise marketing investments in the near to midterm.

    1. HDFC Bank: This bank rose 2.6% in trade on Wednesday following the release of its business update on Monday after market hours. The company reported that its advances grew 17% YoY to 16 lakh crore in Q4FY23. The growth was led by retail, commercial & rural loans, which rose by more than 20%. Corporate and other wholesale loans grew by 12.5% in Q4.

    The bank’s deposits also rose 21% YoY to Rs 18.8 lakh crore, led by a 23.5% increase in retail deposits. This is higher than the industry growth rate of 10%, according to reports. Analysts suggest that HDFC Bank’s market share in deposits at the end of FY23 would stand at 20%, up from 19% as of 9MFY23, which is positive news for the bank.

    The bank also purchased loans worth Rs 9,340 crore in Q4, through a direct assignment route under the home loan arrangement with HDFC. This is a lower-cost route of obtaining funds for the bank. It remains to be seen how the bank’s low cost of funds and high advances growth will impact its margins.

    The stock is up 5.5% in the past week, ahead of its Q4FY23 results on April 15. It has also outperformed its sector by 9.8% in the past 90 days. However, Trendlyne’s Forecaster estimates a 0.9% fall in net profit estimates in Q4FY23. 

    Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.

    1
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    06 Apr 2023
    Screener of the week: Finance sector stocks with high momentum and positive forecaster estimates for Q4FY23

    Screener of the week: Finance sector stocks with high momentum and positive forecaster estimates for Q4FY23

    By Abdullah Shah

    While brokerages are getting squeezed, the overall finance sector is a different story - with multiple stocks analysts are bullish on.

    This screener shows stocks from the banking and finance sector with momentum scores greater than 50, and a strong Q4FY23 result outlook - where estimates for quarterly YoY revenue growth are higher than 10%, and estimates for quarterly net profit growth are more than the previous quarter.

    The screener is dominated by stocks from the banking industry with 12 bank stocks. Major stocks in the screener are Shriram Finance, Karur Vysya Bank, Federal Bank, IDFC First Bank, ICICI Bank and Bank of Baroda.

    Shriram Finance has the highest YoY revenue growth estimates of 71.3% for Q4FY23, according to Trendlyne’s forecaster. The NBFC has a Trendlyne momentum score of 52.7. Over the past quarter, the lender has fallen 4.7%, but has outperformed its industry by 320 bps.

    ICICI Bank has a revenue growth estimate of 29.5% YoY from forecaster for Q4FY23. The bank has a Trendlyne momentum score of 53.4 and has outperformed the banking industry by 5.8 percentage points. 

    You can find more screeners here.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    05 Apr 2023
    Analysts' choice: 5 stocks analysts are bullish on

    Analysts' choice: 5 stocks analysts are bullish on

    By Abhiraj Panchal
    1. Rainbow Childrens Medicare: ICICI Direct initiates a ‘Buy’ call on this healthcare facilities company with a target price of Rs 840. This indicates an upside of 13.6%. Analysts Siddhant Khandekar, Kushal Shah and Utkarsh Jain say that the company has expertise in the most case-sensitive healthcare group of pediatric and perinatal care. They believe that it makes the company “a standout player”.  The healthcare company has planned to expand its presence by adding 850 beds across cities in the next four to five years. 

    Khandekar, Shah and Jain say, “The company’s hub and spoke model will aid growth and accessibility for patients.” Rainbow Childrens Medicare also follows a doctor engagement model where most of its core specialists work at the hospitals on a full-time retainer basis, which the analysts believe has led to a high degree of full-time doctor retention. They expect revenues to touch Rs 1,098 crore, showing an improvement of 13% YoY in FY23. 

    1. Embassy Office Parks REIT: ICICI Securities maintains a ‘Buy’ call on this REIT with a target price of Rs 425, indicating an upside of 35.3%. The company's board has approved the acquisition of Embassy Business Hub, a property under development, for an enterprise value of Rs 330 crore. The acquisition will be funded through debt at an interest cost of 8.1% per annum. Analyst Adhidev Chattopadhyay expects that the rent from phase 1 will commence in Q1FY25 and phase 2 in Q1FY28, and it will derive an enterprise value of Rs 310 crore at an 8% cap rate for the acquisition, which he believes is value-neutral. 

    The analyst remains cautious as the FY23 Union Budget carried a proposal to make the debt repayment/capital return portion of listed REITs taxable from FY24 and currently, 40% of the NDCF distribution profile for Embassy REIT comes from debt repayment which will become taxable from FY24. He concludes, “there may be some relaxation in the final version of the Budget proposal, with debt repayment not being taxed upfront,” for which we await final clarity. 

    1. HG Infra Engineering: IDBI Cap maintains a ‘Buy’ call on this construction and engineering company with a target price of Rs 1,067. This indicates an upside of 34.8%. Analysts Vishal Periwal and Prachi Kadam visited HG Infra’s Ganga expressway project site and interacted with the execution team and management. HG Infra was awarded the Ganga expressway project in Q1FY23, with a project cost of Rs 4,400 crore. The company scheduled the completion by January 2025 but the analysts say, “it is planning on early completion in 24 months, post which they will be eligible for an early completion bonus of Rs 50 crore.”

    HG Infra has maintained its revenue target of growing 25% and 22% YoY in FY23 and FY24, respectively. The analysts expect margins to be in the range of 15%-16%. According to them, it is also eyeing order inflows of Rs 8,000-10,000 crore in FY24. 

    1. InterGlobe Aviation: Prabhudas Lilladher maintains its ‘Buy’ rating on this airliner with a target price of Rs 2,347. This implies an upside of 23.5%. Analysts Jinesh Joshi and Stuti Beria believe that the company is well-placed to capitalise on India’s rapidly growing aviation market as it has a 56% market share in India. They are also positive about the management’s plans to increase the fleet size to 350, expand the network to 115 destinations and increase carrying capacity by FY24. 

    Joshi and Beria believe that the company is “well placed to strongly benefit from higher capacity deployment, network expansion in domestic as well as international markets, lower crude prices and superior industry cost structure in the current environment.” The analysts add that the management’s plan to increase international destinations will drive market share expansion. They expect the company’s revenue to grow at a CAGR of 40% over FY22-25. 

    1. Dalmia Bharat: Axis Direct keeps its ‘Buy’ rating on this cement manufacturer and raises its target price to Rs 2,260 from Rs 2,120. This indicates an upside of 14.6%. Analysts Uttam Kumar Srimal and Shikha Doshi believe that the company’s strategy to continue exiting from its non-core businesses augurs well, as it can focus solely on its cement business. They are also positive about the firm’s capacity expansion plans, and expect its overall cement capacity to touch 49 metric tonnes per annum in FY24. 

    Srimal and Doshi expect demand for cement to grow at a CAGR of 7-8% over FY22-25 on the back of the increased government capex on infrastructure and housing. They believe “with the commissioning of new capacity and cost optimization measures'', the company will be a major beneficiary of the Centre’s infrastructure push. The analysts estimate the cement manufacturer’s net profit to grow at a CAGR of 12% over FY22-25.

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    (You can find all analyst picks here)

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    31 Mar 2023
    Five Interesting Stocks Today

    Five Interesting Stocks Today

    1. Bharat Electronics: This public sector defence company has bagged multiple orders worth nearly Rs 16,300 crore in March for the supply of indigenously developed equipment and electronic warfare systems to the Indian Army, Navy and Air Force. These order wins come after the company’s order inflow fell to a two-year low of Rs 3,500 crore during the first nine months of FY23 due to approval delays.

    The company is expected to be a major beneficiary of the Centre’s push for reducing defence imports, as it commands a market share of 37% in the Indian defence sector. According to Geojit BNP Paribas, the company’s order book backlog of Rs 50,116 crore provides strong revenue visibility over the next three years. The company shows up in a screener for stocks with consistently high returns over the past five years. According to Trendlyne’s Forecaster, the consensus recommendation from 20 analysts is ‘Buy’.

    While the management is optimistic about growth in orders from the defence sector, it plans to diversify into non-defence sectors like healthcare, airports, infrastructure and smart city projects. The firm’s long-term plan is to increase the contribution of its non-defence segment to 25% from 10% of total revenue.

    With the rise in demand for locally manufactured defence systems, the company expects these orders to increase in the coming years. To be able to meet the upcoming requirements, it aims to make five new facilities operational in the next two-three years. It has budgeted a capex of Rs 600 and Rs 600-800 crore for FY23 and FY24 respectively. The management expects revenue to grow in the range of 15-20% in FY24, led by large orders and commissioning of new facilities.

    1. Zydus Lifesciences: This pharmaceutical company reached its 52-week high of Rs 493.2 per share on Wednesday after receiving two US FDA approvals on the same day. The company shows up in a screener of stocks with strong momentum.

    Zydus Lifesciences received final approval from the US FDA for its loperamide hydrochloride capsules, used for the treatment of inflammatory bowel disease, on Tuesday. According to IQVIA, the capsule has had an estimated annual sales of $34.7 million in the year ended January 2023 in the US.

    The company received final approval from the US FDA for its levothyroxine sodium injection as well on Tuesday. The capsules, used for the treatment of myxedema coma, will be manufactured at its facility in Jarod, Gujarat.

    However, it’s not all good news for the company. Earlier in the week (on Sunday), the drug manufacturer announced that it had recalled 55,000 bottles of colchicine tablets after it received an out-of-specification (OOS) result during release testing.

    According to Sharekhan, the drug manufacturer stands to gain from strong product launches and volume growth in the US market, as its revenue of Rs 1,925 crore in Q3FY23 contributed to 44% of the total revenues. The brokerage estimates the company’s revenue to grow at a CAGR of 7.5% during FY22-25 and maintains its ‘buy’ rating on the stock with a target price of Rs 572. Trendlyne’s forecaster estimates its revenue to rise by 9.9% in FY23.

    1. Allcargo Logistics: This logistics company rose over 2.4% on Tuesday after announcing its plan to acquire a 30% stake in Gati-Kintetsu Express for Rs 406.7 crore. Allcargo will buy shares from KWE Singapore (26% stake) and KWE India (4% stake). Gati-Kintetsu Express is a JV of Allcargo’s group company Gati and Kintetsu World Express. Gati deals in overseas courier services, while KWE is a Japanese freight forwarding company.

    Allcargo has been on an acquisition spree over the past few months. The company had also bought the remaining 38.9% stake from its partner, ACCI, in the contract logistics business at an enterprise value of Rs 373 crore earlier this month.

    In January, it bought a 75% stake in German cargo consolidator Fair Trade for 12 million euros, according to reports. Speaking to the media about the company’s recent acquisitions, Ravi Jakhar, the Chief Strategy Officer said the acquisitions were in line with the company’s strategy to simplify the organisational structure, enhance its growth in the domestic supply chain, and strengthen its position in key strategic markets.

    Apart from the acquisitions, the company sold 90% of its logistics parks business to private equity firm Blackstone in February. Allcargo will also sell its non-core customs business.

    However, despite a recent rise in its share price, the company is still down 27.3% from its 52-week high of Rs 495 in November 2022. But, it ranks high on Trendlyne’s checklist with a score of 73.9% and shows up in a screener for stocks with high Piotroski scores.

    1. Jindal Stainless: This metals & mining stock rose 4% in early trade on Wednesday after it announced an acquisition of a 49% stake in Indonesia-based Nickel Pig Iron Co. However, it pared the gains and closed 0.2% lower. Jindal Stainless (JSL) plans to invest $157 million (Rs 1,290 crore) over the next two years to build a facility with a production capacity of 2 lakh metric tonnes. The company’s Managing Director Abhyuday Jindal says that not having backward integration for nickel is a big risk for the nation as we face a deficiency in nickel reserves.

    This acquisition will help the company secure the supply of nickel, a critical raw material used in making alloys. Jindal Stainless has a series of other projects lined up. The company has announced an investment of Rs 120 crore to set up rooftop solar projects in Jajpur and Hisar facilities.

    Sector growth looks decent for JSL as Bank of America Securities has given a positive stance for the near term. It expects steel demand to bounce back, resulting in higher prices. It also expects export opportunities to improve as export duty on steel has been scrapped.

    Although the stock has fallen 5% in the past week, it gained 23.4% in the past three months and outperformed its sector by 3.7% in the past month. Jindal Stainless was a multi-bagger stock last year (gaining nearly 199%) but gained only 43.5% this year. Trendlyne’s Forecaster estimates a 5.7% increase in its annual revenue in FY23.

    1. Sun Pharmaceuticals Industries: Thispharmaceutical giant expects its revenue to take a hit after reporting a ransomware attack on its system in early March. It reported a breach of some files and theft of company and personal data, impacting operations. The firm has isolated its network and started the recovery process. It is also evaluating the expenses for litigation and insurance. The stockfell nearly 3% the following week.

    The firm did a series of acquisitions in Q4FY23, including a 60% stake in Vivaldis Health and Foods for Rs 143 crore in March, US-based Concert Pharmaceuticals for USD 576 million and a minority stake in Agasta Software and Remidio Innovative Solutions.

    Lately, Sun Pharma has been focusing on the domestic market to increase its market share. The US and India each contribute 31% of revenue to the company, while emerging markets contribute 19%. It has nearly 9% share of the pharma market in India. Market share growth coupled with new launches for India formulations have led top-line growth in Q3FY23. Focusing on the global specialty portfolio also led to an increase in the margins. The specialty portfolio contributes nearly 13% of its revenue. The stock shows up in a screener for top Indian exporters among listed companies.

    According to the management, its US portfolio is expected to grow 4.6%, while the India division should rise 7%. Its chronic portfolio is also expected to see strong growth led by new launches.

    ICICI Securities says Sun Pharmaceuticals’ India business will outperform the industry, and global specialty sales will help margin expansion. Meanwhile, profitability will be slightly offset by rising R&D spend.


    Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    31 Mar 2023

    Number of multibagger stocks fell sharply over the past one year

    1
    Copy LinkShare onShare on Share on Share on
     
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd